Robyn Hylind

Associate Director, Molecular Diagnostics Programs at Ultragenyx Pharmaceutical

Robyn Hylind, MS, CGC, currently serves as a Patient Diagnostic Liaison at Ultragenyx since January 2024. Previously, Robyn held positions at Boston Children's Hospital from April 2016 to January 2024, starting as a Cardiovascular Genetic Counselor and advancing to Senior Cardiac Genetic Counselor. Additional experience includes working as an International Client Services Specialist at Veracyte, Inc. from August 2012 to July 2014, and as a Clinical Research Assistant at Cepheid from February 2012 to August 2012. Robyn began professional pursuits as a Genetic Counseling Intern at Stanford University Medical Center in August 2011. Academically, Robyn earned a Master’s Degree in Genetic Counseling/Counselor from Northwestern University - The Feinberg School of Medicine and a Bachelor of Science in Molecular Biology from Santa Clara University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Ultragenyx Pharmaceutical

11 followers

Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.


Industries

Employees

501-1,000

Links